SCHEMBL269579

SCHEMBL269579

CCC(C)CC[C]=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5159997 1.00
SCHEMBL8811486 0.91 LMNA (0.39)
SCHEMBL8811527 0.91 LMNA (0.39)
SCHEMBL8760269 0.87
SCHEMBL17143810 0.84
SCHEMBL1410494 0.84
SCHEMBL17143522 0.84
SCHEMBL17143627 0.82 LMNA (0.35)
SCHEMBL1410630 0.82 LMNA (0.35)
SCHEMBL4100336 0.82 LMNA (0.35)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 806 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070207948-A1 Convergent Synthesis for Kahalalide Compounds PHARMA MAR, S.A.U. (ES) 2007-09-06 US claimed
EP-1749023-A1 CONVERGENT SYNTHESIS FOR KAHALALIDE COMPOUNDS Pharma Mar, S.A.U. (ES) 2007-02-07 EP claimed
WO-2005103072-A1 CONVERGENT SYNTHESIS FOR KAHALALIDE COMPOUNDS PHARMA MAR, S.A.U. (ES) 2005-11-03 WO claimed
EP-0798304-B1 REMEDIES FOR THROMBOCYTOPENIA SUNTORY LTD (JP) 2003-03-12 EP claimed
US-6380197-B1 FOR TREATING AND PREVENTING A PLETHORA OF DISEASES INCLUDING DIABETES AVENTIS PHARMA S. A. (FR) 2002-04-30 US claimed
EP-1001943-A1 POLYHYDROXYALKYLPYRAZINE DERIVATIVES, PREPARATION AND MEDICINES CONTAINING THEM Aventis Pharma S.A. (FR) 2000-05-24 EP claimed
US-6040335-A NOVEL 2-PYRANONE DERIVATIVES SUNTORY LIMITED (JP) 2000-03-21 US claimed
WO-1999003843-A1 POLYHYDROXYALKYLPYRAZINE DERIVATIVES, PREPARATION AND MEDICINES CONTAINING THEM RHONE-POULENC RORER S.A. (FR) 1999-01-28 WO claimed
EP-0622372-B1 New compound, leustroducsin H, its preparation and its therapeutic use SANKYO CO (JP) 1998-05-13 EP claimed
EP-0798304-A1 REMEDIES FOR THROMBOCYTOPENIA SUNTORY LIMITED (JP) 1997-10-01 EP claimed
EP-0622372-A1 New compound, leustroducsin H, its preparation and its therapeutic use SANKYO COMPANY LIMITED (JP) 1994-11-02 EP claimed
JP-7002886-A None JP disclosed
US-20240216389-A1 DRUG FOR PREVENTING AND/OR TREATING POLYCYSTIC KIDNEY DISEASE OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2024-07-04 US disclosed
EP-3837247-B1 SYNTHESIS OF CHROMANOL DERIVATIVES BASF SE (DE) 2024-06-05 EP disclosed
US-20240174601-A1 COMPOSITION COMPRISING HETEROCYCLIC COMPOUND AND 4,4'-METHYLENE DIPHENYL DIISOCYANATE BASF SE (DE) 2024-05-30 US disclosed
EP-0435104-A2 Salicylic acid derivatives, process for their preparation and their use as herbicide and bioregulators BASF Aktiengesellschaft (DE) 1991-07-03 EP disclosed
WO-1991004249-A1 PYRIDINE DERIVATIVES AND A LIQUID CRYSTAL MEDIUM MERCK Patent Gesellschaft mit beschränkter Haftung (DE) 1991-04-04 WO disclosed
EP-0402751-A1 Derivatives of salicylic aldehyde and salicylic acid and sulphur analoges thereof, methodes for preparing them and their use as herbicides and bioregulators BASF Aktiengesellschaft (DE) 1990-12-19 EP disclosed
EP-0346789-A2 Salicylic-acid derivatives and their sulfur analogues BASF Aktiengesellschaft (DE) 1989-12-20 EP disclosed
EP-0269963-A2 Ferroelectric liquid crystals F. HOFFMANN-LA ROCHE AG (CH) 1988-06-08 EP disclosed